The Asian Oncology Society 1st Virtual International Conference

 

Gastrointestinal
18:54

The Asian Oncology Society 1st Virtual International Conference

Genomic Era of CRC Surgery: Total Mesorectal Excision, CME & CVL, TaTME - Does Less Surgery Equaly Improve Survival?

FEATURING Suk-Hwan Lee
  • 89 views
  • February 22, 2021
50:29

The Asian Oncology Society 1st Virtual International Conference

Biomarker Driven and Targeted Therapies in CRC: dMMR/MSI-H, HER2 Overexpression, Heterogeneity, Liquid Biopsies, RAS/RAF, NGS

FEATURING Heinz-Josef Lenz
  • 360 views
  • February 22, 2021
  • 4
16:45

The Asian Oncology Society 1st Virtual International Conference

Systemic Treatment for Advanced HCC: Can Sorafenib Improve PFS/ORR vs. Lenvatinib in Unresectable Disease? Is There OS Benefit With Regorafenib After Sorafenib?

FEATURING Minsig Choi
  • 332 views
  • February 22, 2021
  • 3
14:13

The Asian Oncology Society 1st Virtual International Conference

IO in Advanced HCC: Can We Achieve Better ORR With 1L Nivo+Ipi? Does 2L Pembro Improve PFS/OS? Is Atezo+Bev Combo Efficient in Unresectable Disease?

FEATURING Minsig Choi
  • 150 views
  • February 22, 2021
  • 1
14:19

The Asian Oncology Society 1st Virtual International Conference

NGS for Pancreatobiliary Cancer: Maintenance Olaparib Data in Germline BRCA-Mutated Metastatic Disease, ctDNA vs. Tissue-Based Testing

FEATURING Minsig Choi
  • 354 views
  • February 22, 2021
  • 1
22:56

The Asian Oncology Society 1st Virtual International Conference

Managing Gastric Cancer: Can Genetic Analysis and NGS Help? Should We Still Use S1 Regimen With Oxaliplatin & Docetaxel for Stage 4 Disease? Is D2 Lymphadenectomy a Standard Surgical Approach?

FEATURING Kazuhiro Yoshida
  • 32 views
  • February 22, 2021
11:02

The Asian Oncology Society 1st Virtual International Conference

Present & Future of Targeted Therapy for Advanced CRC: IO for dMMR/MSI-H Disease, RAS/BRAF Mutations, AMG510, Encorafenib+Binimetinib+Cetuximab, T-DXd for HER2+ mCRC

FEATURING Jin Li
  • 211 views
  • February 18, 2021